PRINCIPLE trial finds no benefit from antibiotics, azithromycin and doxycycline for COVID-19 patients, NIHR

A NIHR-supported study investigating potential COVID-19 treatments that might be suitable for patients in the community has found that the commonly used antibiotics, azithromycin and doxycycline, do not reduce recovery time for patients.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news